Our 3D InSight™ Oncology platform mimics the physiology and the heterogeneity of the tumor microenvironment and patient-specific characteristics, offering a reliable, accurate in vitro model to test your pipeline of innovative cancer therapeutics. Our 3D InSight™ Oncology platform allows you to get robust, reproducible, and physiologically relevant results for any therapeutic candidate in your discovery program with days to weeks turnaround times.
Why Therapeutic Modality Screening with InSphero?
We inspire researchers, worldwide, to reach their full potential so that life changing therapies can ultimately make it into the hands of patients.
The leading 3D tumor technology to answer your questions
Build the right genomically characterized tumor model to answer a specific biological question
Validate your targets in highly biologically relevant 3D tumor models
Our platform gives you the ability to understand target engagement and efficacy in the context of a physiologically relevant tumor microenvironment
Data you can trust for our crucial decisions
Make decisions about your oncology portfolio with data you can trust
Visualize the effect of different inter-cellular interactions in action
Change the composition of the tumor microtissue to understand the contribution of each cell type to therapeutic resistance